Insulin resistance and type 2 diabetes: time for a new hypothesis.
Stubbs
R S
RS
Wakefield Gastroenterology Centre, Wakefield Hospital, Wellington.
Wickremesekera
S K
SK
D000682:Amyloid / Q000378:metabolism; D000818:Animals; D003924:Diabetes Mellitus, Type 2 / Q000378:metabolism*; D005230:Fatty Acids, Nonesterified / Q000378:metabolism; D005749:Gastric Inhibitory Polypeptide / Q000378:metabolism; D005934:Glucagon / Q000378:metabolism; D052216:Glucagon-Like Peptide 1; D006801:Humans; D007333:Insulin Resistance; D058228:Islet Amyloid Polypeptide; D020738:Leptin / Q000378:metabolism; D051379:Mice; D010446:Peptide Fragments / Q000378:metabolism; D011498:Protein Precursors / Q000378:metabolism; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
D000682:Amyloid; D005230:Fatty Acids, Nonesterified; D058228:Islet Amyloid Polypeptide; D020738:Leptin; D010446:Peptide Fragments; D011498:Protein Precursors; D014409:Tumor Necrosis Factor-alpha; D005749:Gastric Inhibitory Polypeptide; D052216:Glucagon-Like Peptide 1; D005934:Glucagon